Stockscreener 앱 받기
2.68
2.68%
0.07
Alaunos Therapeutics Inc 주식(TCRT)의 최신 뉴스
MSN Money - MSN
Former Alaunos legal chief joins Valion Bio for FDA, CDMO push - Stock Titan
Valion Bio Appoints Melinda Lackey as General Counsel - Sahm
TCRT Alaunos Therapeutics posts wider Q4 2023 loss than analyst estimates, with shares slipping 0.39 percent in today’s trading.Social Trading Insights - Newser
Alaunos Therapeutics (TCRT) director awarded 6,515 shares at $2.59 - Stock Titan
Alaunos Therapeutics (TCRT) director receives 6,274-share stock grant in lieu of fees - Stock Titan
Director at Alaunos (TCRT) receives 6,032-share stock award - Stock Titan
Alaunos Therapeutics 2025 Proxy Statement – Board Members, Executive Compensation, and Corporate Governance Overview - Minichart
TCRT Stock Price, Quote & Chart | ALAUNOS THERAPEUTICS INC (NASDAQ:TCRT) - ChartMill
Alaunos Therapeutics (NASDAQ: TCRT) details board, pay and ownership in 10-K/A - Stock Titan
Alaunos Therapeutics (TCRT) Moat Analysis | Q4 2023: EPS Misses EstimatesStability Report - Xã Châu Thành
Alaunos Therapeutics receives Nasdaq notice for non-compliance with equity rule - Investing.com
Alaunos Therapeutics Faces Nasdaq Non-Compliance, Delisting Risk - TipRanks
Alaunos Therapeutics Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Alaunos Therapeutics (NASDAQ: TCRT) faces Nasdaq equity deficiency, delisting risk - Stock Titan
Aug Update: How does Alaunos Therapeutics Inc correlate with Nasdaq2026 Market WrapUp & Long Hold Capital Preservation Plans - baoquankhu1.vn
TCRT Technical Analysis & Stock Price Forecast - Intellectia AI
TCRT PE Ratio & Valuation, Is TCRT Overvalued - Intellectia AI
TCRT Stock Analysis: Alaunos Therapeutics Inc rises 3.15 pct near 3 dollar level - Cổng thông tin điện tử tỉnh Lào Cai
Ziopharm: Q4 Earnings Snapshot - 10tv.com
Alaunos Therapeutics 10-K: Revenue $0.005M, Net loss $4.176M - TradingView — Track All Markets
Cash runway, Nasdaq risks and obesity focus at Alaunos (TCRT) - Stock Titan
Inflation Data: Should value investors consider Alaunos Therapeutics IncQuarterly Investment Review & Community Consensus Trade Signals - baoquankhu1.vn
Weight loss data from obese mice looks promising for Alaunos Therapeutics, but shares drop - MSN
Aug Update: Is Alaunos Therapeutics Inc a cyclical or defensive stockTrend Reversal & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn
Contrasting Xeris Biopharma (NASDAQ:XERS) and Alaunos Therapeutics (NASDAQ:TCRT) - Defense World
TCRT,MLAC Revenue Breakdown - Finviz
Decliners Report: Can Alaunos Therapeutics Inc stock double in the next year2026 Trading Recap & Accurate Buy Signal Alerts - baoquankhu1.vn
Aug Patterns: Is Alaunos Therapeutics Inc forming a bullish divergence2026 Dividend Review & Weekly Setup with High ROI Potential - baoquankhu1.vn
Short Interest in Alaunos Therapeutics, Inc. (NASDAQ:TCRT) Decreases By 14.3% - Defense World
Shareholder group in Alaunos Therapeutics (TCRT) proposes $7M control-shifting investment - Stock Titan
Will Alaunos Therapeutics Inc benefit from rate cutsJuly 2025 Macro Moves & Safe Capital Growth Plans - baoquankhu1.vn
Alaunos reports early obesity drug data from mouse studies - Investing.com South Africa
TCRT SEC FilingsAlaunos Therapeutics, Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Weight Loss Data From Obese Mice Looks Promising For Alaunos Therapeutics, But Shares Drop - Benzinga
Alaunos reports findings with ALN-1003 in DIO mouse model - bioworld.com
Alaunos Reports Positive Preclinical Data for Obesity Candidate - TipRanks
Alaunos Therapeutics Announces Positive Preclinical Proof-of-Concept Data for ALN1003, a Differentiated Non-Hormonal Oral Treatment for Obesity and Related Metabolic Disorders - The Manila Times
Alaunos Therapeutics reports positive preclinical ALN1003 data showing dose-dependent weight loss, liver improvements - TradingView
Non-hormonal obesity pill helps mice lose weight, improve liver health - Stock Titan
TCRT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Alaunos Therapeutics | SCHEDULE 13D/A: Others - Moomoo
Short Interest in Alaunos Therapeutics, Inc. (NASDAQ:TCRT) Drops By 14.6% - Defense World
Chart Watch: Can Alaunos Therapeutics Inc stock double in the next yearJuly 2025 Price Swings & Fast Momentum Stock Entry Tips - baoquankhu1.vn
Will Alaunos Therapeutics Inc. face regulatory challengesMarket Volume Summary & Fast Moving Stock Trade Plans - mfd.ru
How does Alaunos Therapeutics Inc. correlate with NasdaqJuly 2025 Reactions & Precise Buy Zone Tips - mfd.ru
Will Alaunos Therapeutics Inc. stock see PE expansion2025 Market WrapUp & Real-Time Buy Signal Alerts - mfd.ru
Published on: 2026-02-11 00:02:19 - baoquankhu1.vn
Alaunos Therapeutics Pivots to Obesity Drug Development in Race Against Time - AD HOC NEWS
Buybacks Report: Is Alaunos Therapeutics Inc a turnaround storyWeekly Earnings Recap & High Win Rate Trade Tips - baoquankhu1.vn
S P Trends: Should value investors consider Alaunos Therapeutics Inc.2025 Key Lessons & Stepwise Trade Signal Guides - mfd.ru
Swing Trade: Is Alaunos Therapeutics Inc a turnaround story2025 Price Targets & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
0.78%
3.01%
자본화:
|
볼륨(24시간):